Age-related hearing loss (ARHL) impacts approximately one-third of individuals over the age of 65. While genetics is known to play an important role in ARHL, our understanding of the precise genetic factors remains incomplete. This presentation will outline how the research team used genomic and audiologic data from the Canadian Longitudinal Study on Aging (CLSA) to bridge this knowledge gap. This talk will provide exciting updates on how by combining automated phenotyping strategies with large-scale data from the CLSA, the researchers have been able to uncover genes involved in various age-related hearing traits.
Dr. Britt Drögemöller holds a Tier 2 Canada Research Chair in Pharmacogenomics and Precision Medicine. Dr. Drögemöller received her PhD from Stellenbosch University in 2013 and continued her training in pharmacogenomics and precision medicine at the University of British Columbia, where she completed a postdoctoral fellowship at the Canadian Pharmacogenomics Network for Drug Safety. Dr. Drögemöller’s research focuses on using large-scale genomic and computational analyses to understand the genetics underlying hearing traits, such as age-related hearing loss.
